Jinghua Pharmaceutical Group Company Description

Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China and internationally.

The company offers active pharmaceutical ingredients (APIs) and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal herbs and materials, health products, and Western medicine products.

It also provides Jidesheng antivenomous tablets, Nantong Wang’s baby health pill, Ningning ZhengChaihu granules, Dachaihu granules, Gubenkechuan tablets, dizziness treatment syrup, and Jinqiaomai tablets; and APIs, such as phenobarbital, primidone, fluorouracil, phenylbutazone, flucytosine, piroxicam, tenoxicam, and propylthiouracil.

In addition, the company engages in enterprise management; technical services; goods and technology import and export; chemical wholesale; pharmaceutical retail; medical devices equipment sales; provision of cosmetics and skincare products; and investment activities.

The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is headquartered in Nantong, China.

Jinghua Pharmaceutical Group Co., Ltd.

Country	China
Founded	1957
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,462
CEO	Jian Cheng

Contact Details

Address: Building A, Guocheng Life Plaza Office Building Nantong, Jiangsu Province 226001 China
Phone	86 513 8560 9118
Website	ntjhzy.com

Stock Details

Ticker Symbol	002349
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100000L14
SIC Code	2834

Key Executives

Name	Position
Jian Cheng	GM, Chief Financial Officer and Director
Yuxiang Wu	Vice Chairman
Jianfeng Wang	Board Secretary
Qianyong Zhu	Deputy General Manager
Li Zhao	Accounting Supervisor
Yan Juan Shen	Deputy General Manager